Ignite Creation Date:
2025-12-24 @ 1:52 PM
Ignite Modification Date:
2026-02-10 @ 2:35 PM
Study NCT ID:
NCT00505895
Status:
COMPLETED
Last Update Posted:
2014-10-17
First Post:
2007-07-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
FM 140 vs FM100 Study in Patients With Multiple Myeloma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Multiple Myeloma | View |
| None | Fludarabine | View |
| None | Fludara | View |
| None | Fludarabine Phosphate | View |
| None | Melphalan | View |
| None | Alkeran | View |
| None | Stem Cell Infusion | View |
| None | Stem Cell Transfusion | View |
| None | SCT | View |
| None | Allogeneic Peripheral Blood Stem Cell Transfusion | View |
| None | APBSCT | View |
| None | Bone Marrow Transplantation | View |
| None | BMT | View |
| None | Rituxan | View |
| None | Rituximab | View |
| None | FM140 | View |
| None | FM100 | View |